Leadership Team

Ben Zeskind, PhD, MBA

Co-Founder and CEO

Ben Zeskind, PhD, MBA

Co-Founder and CEO

Dr. Zeskind is our co-founder and CEO. Over the past seven years, he and his colleagues have established Immuneering as a trusted advisor to leading pharmaceutical companies, pioneering new ways to use biological data for the benefit of patients. Dr. Zeskind is an inventor on numerous patents assigned to both Immuneering's clients and the company itself, and he has published extensively in peer-reviewed journals. He trained at the Massachusetts Institute of Technology, earning a Ph.D. in Bioengineering in 2006 and an SB in Electrical Engineering and Computer Science in 2003. He also earned an MBA at Harvard Business School, where he was recognized as a Baker Scholar, the highest award for distinction.

Kevin D. Fowler, PhD

Vice President, Translational Research

Kevin D. Fowler, PhD

Vice President, Translational Research

Dr. Fowler brings deep expertise in biology and computational biology to our team. He joined Immuneering after completing his Ph.D. in Chemical Engineering at the Massachusetts Institute of Technology. His doctoral research was focused on computational immunology and signal integration in immune cell biology, and he conducted research at Harvard Medical School.

Sarah Kolitz, PhD

Vice President, Translational Medicine

Sarah Kolitz, PhD

Vice President, Translational Medicine

Dr. Kolitz brings expertise in teasing apart biological mechanisms to our team. She conducted her postdoctoral research in Biological Engineering at the Massachusetts Institute of Technology, after earning a Ph.D. in Biophysics and Biophysical Chemistry from the Johns Hopkins University School of Medicine.

Rebecca Kusko, PhD

Vice President, Genomics

Rebecca Kusko, PhD

Vice President, Genomics

Dr. Kusko is a computational biologist with expertise in translating NGS and other genomic data to clinical discoveries. She has integrated directly with clinicians on study design, as well as with lab scientists in functional genomics, to plan molecular biology and validation experiments. After completing her undergraduate degree in Biological Engineering at Massachusetts Institute of Technology, she went on to complete her Ph.D. in Computational Biomedicine at the Boston University School of Medicine. Her doctoral thesis focused on the transcriptome in Chronic Obstructive Pulmonary Disease, or COPD, and lung cancer in non-smokers.

Andrew Lysaght, PhD

Vice President, Bioinformatics

Andrew Lysaght, PhD

Vice President, Bioinformatics

Dr. Lysaght integrates years of experience with biological expression data together with a rigorous background in engineering fundamentals to provide expertise in customized data analysis with an eye for practical and actionable results. He earned a Ph.D. from the joint Harvard-MIT Program in Health Sciences and Technology, where he worked alongside leading clinicians of the Massachusetts Eye and Ear Infirmary to identify changes in inner ear transcription and translation during delayed onset hearing loss.

Yoonjeong Cha

Associate Director, Genomics

Yoonjeong Cha

Associate Director, Genomics

Since joining Immuneering, Ms. Cha has developed an expertise in multi-omic integration and mutation prioritization in cancer data. She holds a B.S. in Computer Science and Molecular Biology from the Massachusetts Institute of Technology. Before graduating, she spent a year in a bioinformatics lab at Seoul National University working on a method to identify differentially expressed signaling pathways. She also spent a summer at the Robert Koch Institute in Berlin, Germany, analyzing genomic and proteomic data from viruses. She won first place in the 10th Annual Merck/BE-BMES Undergraduate Research Poster Session.

Gregory Koytiger, PhD

Senior Director, Systems Pharmacology

Gregory Koytiger, PhD

Senior Director, Systems Pharmacology

Dr. Koytiger brings expertise analyzing complex networks to gain insight into disease mechanisms. He completed his PhD working in both the Department of Systems Biology in Harvard Medical School and Harvard's Department of Chemistry and Chemical Biology. There he analyzed the network properties of oncogenes and built a predictive model to assess the quantitative impact of cancer mutations on interaction networks.

Jenny Zhang, PhD

Associate Director, Genomic Data Science

Jenny Zhang, PhD

Associate Director, Genomic Data Science

Dr. Zhang extracts actionable insights from genomic data by combining cutting-edge data science techniques with expertise in experiment design and cancer biology. During her data science fellowship at The Data Incubator, she utilized distributed computing, network analysis, and machine learning to reveal patterns within large textual and numerical datasets. She graduated from the Massachusetts Institute of Technology with a B.S. in Physics, and Duke University with a Ph.D. in Genetics and Genomics. In her doctoral work, she developed novel experimental and bioinformatic methods to generate and analyze terabytes of next-generation sequencing data towards understanding the mutational underpinnings of lymphoma.

Jermaine Ross, PhD

Associate Director, Translational Medicine

Jermaine Ross, PhD

Associate Director, Translational Medicine

For over a decade, Dr. Ross studied at the National Institutes of Health, where he designed and conducted original research in the field of bioinformatics and comparative genomics. His work has been recognized for enhancing computational methods to identify and analyze molecular mechanisms that regulate neurogenesis. Ross has developed and employed machine learning and bioinformatic algorithms to decode the combinatorial logic of noncoding DNA that control gene expression programs. He earned his PhD degree in Neuroscience from Brown University.

Renan Escalante, PhD

Associate Director, Systems Biology

Renan Escalante, PhD

Associate Director, Systems Biology

Dr Escalante Chong is passionate about integrating the massive amounts of data generated in modern biology to transform disease management and treatment. He did his PhD at the Department of Systems Biology at Harvard Medical School where he used quantitative molecular genetics to dissect signaling pathways. He completed his postdoctoral training at the Department of Biological Engineering at MIT where he worked with the interdisciplinary teams of neuroLINCS and answerALS to generate molecular signatures of the neurodegenerative diseases ALS and SMA.

Jason Funt, PhD

Vice President, Computational Biology

Jason Funt, PhD

Vice President, Computational Biology

Dr. Funt’s focus is in synthesizing actionable insight from complex, heterogeneous high-dimensional data. He earned his Ph.D. in Computational and Systems Biology from MIT’s Biology Department.  His thesis research, at both MIT and the Broad Institute, focused on mapping evolutionary pathways of drug resistance from genomic and transcriptomic profiling of the pathogen Candida albicans.

Matthew Ung, PhD

Associate Director, Systems Pharmacology

Matthew Ung, PhD

Associate Director, Systems Pharmacology

Dr. Ung is a computational biologist with extensive experience in applying data science techniques to extract translational insight from biological and disease data. Dr. Ung received his PhD from the Geisel School of Medicine at Dartmouth in the Department of Molecular and Systems Biology. During this time, he primarily focused on developing computational approaches to integrate diverse genomic and clinical datasets to pinpoint the genetic aberrations underlying several cancer types and to identify potential therapeutic candidates. In addition, Dr. Ung’s interdisciplinary background has allowed him to author and co-author several studies across diverse topics including experimental pharmacology, epidemiology, epigenetics, and biological networks.

Melissa Martin

Executive Administrative Assistant

Melissa Martin

Executive Administrative Assistant

Ms. Martin has several years of experience in office administration in various industries, as well as a broad background in customer relations, social media and marketing, human resources and recruiting, and finance. She holds a B.S. in Communications from Fitchburg State University.